KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition. (2019)

First Author: Magloire V
Attributed to:  Gene therapy for refractory epilepsy funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-08933-4

PubMed Identifier: 30874549

Publication URI: http://europepmc.org/abstract/MED/30874549

Type: Journal Article/Review

Volume: 10

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723